Avoiding the Risk of Bleeding from Pradaxa: FDA Provides Additional Information for Patients

By Thomas Greer | January 26, 2015

On December 7, 2011, the Food and Drug Administration (FDA) made an announcement that it would be conducting a safety review of the drug Pradaxa, which is used to treat a common type of heart rhythm abnormality. For a better understanding of how Pradaxa can lead to serious bleeding, watch this free pradaxa video.

The FDA also made several recommendations for patients taking Pradaxa. For instances, the FDA recommends that patients taking Pradaxa should call their doctor or healthcare provider and seek immediate medical attention if any of the following signs or symptoms appear:

  • unusual bleeding from the gums
  • nose bleeding that happens often
  • menstrual or vaginal bleeding that is heavier than normal
  • bleeding that is severe or you cannot control
  • pink or brown urine
  • red or black stools (looks like tar)
  • bruises that happen without a known cause or that get larger
  • coughing up blood or blood clots
  • vomiting blood or vomit that looks like coffee grounds.

The FDA is also encouraging patients to report any side effects to the FDA MedWatch program.

Protect Your Legal Rights Against the Makers of Pradaxa

If you or someone you know experienced a bleeding event while taking the drug Pradaxa, call and speak to one of our experienced nationwide defect drug attorneys today.  We are handling Pradaxa cases accross the country.  Call us for a free consultation today at 1-877-819-4414.

Posted in Drugs and Medical Devices, Library